Market Overview

The Global Gout Therapeutics Market was valued at USD 2,920.7 million in 2023 and is expected to reach USD 5,170.4 million by 2031 while growing at a CAGR of 7.4% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global gout therapeutics Market growth. Gout therapeutics encompass the array of treatment options aimed at managing gout, an inflammatory arthritis resulting from uric acid crystal deposition in the joints. These therapies aim to alleviate pain and inflammation during acute attacks, prevent recurrence, and mitigate the risk of chronic gout-related joint damage and complications.

The increasing prevalence of gout, coupled with growing awareness and diagnosis, propels the gout therapeutics market. Nonetheless, the market's growth is impeded by the high cost of treatment and concerns regarding safety and tolerability.

Furthermore, the global gout therapeutics industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Drug Class Analysis

The Global Gout Therapeutics Market is segmented among NSAIDs, Corticosteroids, Colchicine, Urate-Lowering Agents, and Others, based on Drug Class. In 2023, NSAIDs accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Application Analysis

The Global Gout Therapeutics Market is segmented among Acute Gout, and Chronic Gout, based on Application. In 2023, Acute Gout accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Gout Therapeutics Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Takeda Pharmaceutical Company Ltd., Novartis Ag, Regeneron Pharmaceuticals Inc., Astrazeneca Plc, Horizon Therapeutics Plc, Merck & Co. Inc, Zydus Group, Teijin Ltd, Glaxosmithkline Plc.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Gout Therapeutics Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Gout Therapeutics Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Gout Therapeutics Market Segmentation, By Drug Class

• Global Gout Therapeutics Market Share Analysis, By Drug Class

• Global Gout Therapeutics Market Growth Analysis, By Drug Class

• Global Gout Therapeutics Market Trends, By Drug Class

o NSAIDs

o Corticosteroids

o Colchicine

o Urate-Lowering Agents

o Others

6. Global Gout Therapeutics Market Segmentation, By Application

• Global Gout Therapeutics Market Share Analysis, By Application

• Global Gout Therapeutics Market Growth Analysis, By Application

• Global Gout Therapeutics Market Trends, By Application

o Acute Gout

o Chronic Gout

7. Global Gout Therapeutics Market Segmentation, By Distribution Channel

• Global Gout Therapeutics Market Share Analysis, By Distribution Channel

• Global Gout Therapeutics Market Growth Analysis, By Distribution Channel

• Global Gout Therapeutics Market Trends, By Distribution Channel

o Hospital Pharmacies

o Retail Pharmacies

o Online Pharmacies

8. Global Gout Therapeutics Market Segmentation, By Region

• Global Gout Therapeutics Market Share Analysis, By Region

• Global Gout Therapeutics Market Growth Analysis, By Region

• Global Gout Therapeutics Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

9. Competitive Landscape

• Takeda Pharmaceutical Company Ltd*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Novartis Ag

• Regeneron Pharmaceuticals Inc.

• Astrazeneca Plc

• Horizon Therapeutics Plc

• Merck & Co. Inc

• Zydus Group

• Teijin Ltd

• Glaxosmithkline Plc

*Similar analysis will be provided for each company listed above.